Résultats de la recherche - 125 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
cancer screening data and the national cancer registry, demonstrates excellent protection against invasive cervical cancer among girls immunized at the age of 12 to 13 years with the bivalent human ...
Equivalent Clinical Accuracy of Human Papillomavirus DNA Testing Using Cobas 4800 and 6800 Human Papillomavirus Systems in Paired Urine and Cervical Samples.
cervical cancer screening is gaining international attention, although more data on the relative clinical accuracy of validated human papillomavirus (HPV) DNA tests on urine versus cervical samples are ...
Women’s perceptions and preferences toward HPV self-sampling in France: A questionnaire within the French CapU4 Trial
Rexand-Galais, Franck; Donders, Gilbert; Lefeuvre, Caroline Source: Journal of Infection and Public Health, Volume 18, Issue 8 (2025) Keywords: cervical cancer HPV Preferences SCREENING self-sampling Abstract: ...
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
to international criteria is prerequisite for their implementation in cervical cancer screening. OncoPredict HPV Quantitative Typing (QT) assay (Hiantis Srl, Milan, Italy) is a novel full-genotyping ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
a strategy to eliminate cervical cancer as a public health problem, the World Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical pre-cancerous lesions in 2021. Women ...
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
screening in a screen-and-treat or screen-triage-and-treat approach, starting from age 30 years with screening every 5 years or 10 years. Health Topics: Human papillomavirus (HPV) and cervical cancer ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
Organised Cervical Cancer Screening Programme (OCCSP) was started in Poland in 2006/2007. Each woman aged 25 to 59 is eligible for a free Pap test every 3 years in OCCSP. Despite implementation of the OCCSP, ...
Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
Source: Br J Cancer (2023) Keywords: Cervical cardiogenesis Cervical lesions HPV Abstract: BACKGROUND: Cervical carcinogenesis is mediated by the HPV- E6 and E7 oncoproteins, considered as biomarkers usable ...
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis.
in comprehensive HPV prevention strategies to reduce HPV-related morbidity and mortality in men and ultimately achieve elimination of cervical cancer and other HPV-related diseases. FUNDING: Instituto ...